ArticleFrontiers in oncology2026
Development and expert radiologist validation of a custom pipeline for simplification of oncology radiology reports using large language model.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Radiology reports are often written for clinicians and contain complex medical terminology, which patients struggle to understand. This comprehension gap may lead to anxiety and misinformed decisions. This is especially important in cancer care. Large language models (LLMs) provide an opportunity to bridge this gap. Direct use of LLM by patients may potentially be misleading and may not ensure clinical fidelity. We developed an LLM- based tool to automatically translate radiology findings into clear, patient-friendly language which could improve patient-centered care. Objective: To develop and validate a bilingual LLM driven tool that simplifies oncology radiology reports into patient-understandable English and Hindi, while maintaining diagnostic fidelity and emotional tone. Methods: This study was approved by the Institute's ethics committee. A retrospective corpus of 100 computed tomography (CT) reports (April 2025-July 2025) of patients with colo-rectal cancers were used for the development of the pipeline. Five large language models-GPT-4o, Gemini 2.5 Pro, Claude Opus, LLaMA-3.1-8B and Phi-3.5-mini-were tested. Five iterative prompt versions guided LLMs through successive refinements to ensure medical accuracy, clarity, and inclusion of a standard disclaimer. A custom pipeline; Vernacular Language Coverter(VLC), based on Gemini 2.5 Pro that takes a radiologist's report as input and generates two patient-facing outputs: (1) a simplified English and (2) a Hindi explanation was developed. The tool thus developed was then prospectively validated using 100 de-identified reports. Simplified outputs were reviewed by two radiologists, assessing accuracy, language clarity/Terminology and readability/tone. Completeness was assessed in terms of core diagnostic completeness and minor incompleteness. Flesch Reading Ease (FRE) was calculated for a fraction of reports. Results: Mean rubric scores were high: Accuracy 4.77 ± 0.62, language clarity/Terminology 4.78 ± 0.56 and readability/tone 4.9 ± 0.32. Core diagnostic completeness was attained in all patients. 92% percent of reports were released 'as is. Readability improved markedly (Flesch Reading Ease 49.2→73). Empathy phrases in English and Hindi were appropriate. Conclusions: An AI-driven bilingual framework significantly enhances the clarity, tone, and readability of oncology radiology reports while retaining diagnostic precision. This tool demonstrates the feasibility of safe, patient-centered communication aligned with the goals of personalized medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.